Follow
Biopharmaceutical
Biopharmaceuticals are medical drugs produced using biotechnology. They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other than direct extraction from a native (non-engineered) biological source. The first such substance approved for therapeutic use was recombinant human insulin.
-
SEP 02, 2018Genetics & Genomics
By sequencing the opium poppy's DNA, scientists have revealed important details about how it makes its medicine.Written By: Carmen LeitchAPR 09, 2018Drug Discovery & Development
Transthyretin amyloidosis (ATTR) is a slowly progressive disease characterized by the buildup of abnormal deposits of a ...Written By: Nouran AminJAN 31, 2018Neuroscience
Getting medication to the brain can be a tricky business. The blood-brain-barrier is designed to prevent toxic substance ...Written By: Brenda Kelley KimNOV 16, 2017Immunology
With any cancer, developing treatments is difficult because cancer cells are an abnormal version of healthy cells. Any d ...Written By: Kara MarkerAPR 28, 2017Clinical & Molecular DX
Every year, millions of doses of life-saving vaccines are destroyed due to temperature breaches en route or while in sto ...FEB 21, 2017Health & Medicine
February 21, 2017 – Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimo ...Written By: The Scripps Research Institute (TSRI)AUG 12, 2016Health & Medicine
A lot of diseases and conditions are treated with biologics or biopharmaceuticals. Biopharmaceuticals are inherently mor ...Written By: Cassidy ReichAUG 08, 2016Health & Medicine
LA JOLLA, CA – August 8, 2016 – Scientists at The Scripps Research Institute (TSRI) now have a high-resoluti ...Written By: The Scripps Research Institute (TSRI)SEP 11, 2015Health & Medicine
One Michigan-based company thinks algae may hold a cure for blindness. RetroSense Therapeutics will soon conduct a ...Written By: Kerry EvansAPR 29, 2015Cancer
Molecular Health announced it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor". ...Written By: Ilene SchneiderAPR 22, 2015Cancer
One of the main sessions at this year's Experimental Biology Conference in Boston was the Tang Prize Award lecture. It w ...Written By: Ilene SchneiderAPR 07, 2015Cancer
Biopharmaceutical firm Berg is joining forces with two prominent Harvard-affiliated medical research institutions, the P ...Written By: Ilene SchneiderMAR 27, 2015Genetics & Genomics
At least, that's what researchers have concluded after sequencing the genomes of 2,636 Icelanders.
A recent ...Written By: Robert WoodardMAR 04, 2015Immunology
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston, and The Scripps Research Inst ...Written By: Judy O'RourkeJAN 20, 2015Health & Medicine
What are the key healthcare trends of 2014? Which ones might be a factor next year and in subsequent years?
A ...Written By: Ilene SchneiderOCT 03, 2014Health & Medicine
It is rare to see a new business segment emerge in any market, but this is what is happening within the biopharmaceutica ...Written By: Ilene SchneiderSEP 08, 2014Microbiology
A massive global collaborative effort is under way to understand how the Ebola virus affects cells, why the virus is let ...Written By: Judy O'RourkeAUG 21, 2014Microbiology
The Intellectual Property and Science business of Thomson Reuters released a comprehensive disease profile on Ebola Viru ...Written By: Ilene SchneiderJUN 10, 2014Cardiology
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to ...Written By: Ilene SchneiderJUN 04, 2014Health & Medicine
A collaboration between Netherlands-based arGEN-X -- a clinical-stage biopharmaceutical company focused on creating and ...Written By: Ilene Schneider
SEP 02, 2018
Genetics & Genomics
By sequencing the opium poppy's DNA, scientists have revealed important details about how it makes its medicine.
Written By:
Carmen Leitch
APR 09, 2018
Drug Discovery & Development
Transthyretin amyloidosis (ATTR) is a slowly progressive disease characterized by the buildup of abnormal deposits of a
...
Written By:
Nouran Amin
JAN 31, 2018
Neuroscience
Getting medication to the brain can be a tricky business. The blood-brain-barrier is designed to prevent toxic substance
...
Written By:
Brenda Kelley Kim
NOV 16, 2017
Immunology
With any cancer, developing treatments is difficult because cancer cells are an abnormal version of healthy cells. Any d
...
Written By:
Kara Marker
APR 28, 2017
Clinical & Molecular DX
Every year, millions of doses of life-saving vaccines are destroyed due to temperature breaches en route or while in sto
...
FEB 21, 2017
Health & Medicine
February 21, 2017 – Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimo
...
Written By:
The Scripps Research Institute (TSRI)
AUG 12, 2016
Health & Medicine
A lot of diseases and conditions are treated with biologics or biopharmaceuticals. Biopharmaceuticals are inherently mor
...
Written By:
Cassidy Reich
AUG 08, 2016
Health & Medicine
LA JOLLA, CA – August 8, 2016 – Scientists at The Scripps Research Institute (TSRI) now have a high-resoluti
...
Written By:
The Scripps Research Institute (TSRI)
SEP 11, 2015
Health & Medicine
One Michigan-based company thinks algae may hold a cure for blindness. RetroSense Therapeutics will soon conduct a
...
Written By:
Kerry Evans
APR 29, 2015
Cancer
Molecular Health announced it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor".
...
Written By:
Ilene Schneider
APR 22, 2015
Cancer
One of the main sessions at this year's Experimental Biology Conference in Boston was the Tang Prize Award lecture. It w
...
Written By:
Ilene Schneider
APR 07, 2015
Cancer
Biopharmaceutical firm Berg is joining forces with two prominent Harvard-affiliated medical research institutions, the P
...
Written By:
Ilene Schneider
MAR 27, 2015
Genetics & Genomics
At least, that's what researchers have concluded after sequencing the genomes of 2,636 Icelanders.
A recent ...
A recent ...
Written By:
Robert Woodard
MAR 04, 2015
Immunology
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston, and The Scripps Research Inst
...
Written By:
Judy O'Rourke
JAN 20, 2015
Health & Medicine
What are the key healthcare trends of 2014? Which ones might be a factor next year and in subsequent years?
A ...
A ...
Written By:
Ilene Schneider
OCT 03, 2014
Health & Medicine
It is rare to see a new business segment emerge in any market, but this is what is happening within the biopharmaceutica
...
Written By:
Ilene Schneider
SEP 08, 2014
Microbiology
A massive global collaborative effort is under way to understand how the Ebola virus affects cells, why the virus is let
...
Written By:
Judy O'Rourke
AUG 21, 2014
Microbiology
The Intellectual Property and Science business of Thomson Reuters released a comprehensive disease profile on Ebola Viru
...
Written By:
Ilene Schneider
JUN 10, 2014
Cardiology
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to
...
Written By:
Ilene Schneider
JUN 04, 2014
Health & Medicine
A collaboration between Netherlands-based arGEN-X -- a clinical-stage biopharmaceutical company focused on creating and
...
Written By:
Ilene Schneider